Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 97

1.

Genetic and environmental influences on corticostriatal circuits in twins with autism

Hegarty II JP, Lazzeroni LC, Raman MM, Hallmayer JF, Cleveland SC, Wolke ON, Phillips JM, Reiss AL, Hardan AY.

J Psychiatry Neurosci. 2019 Oct 11;44(6):190030. doi: 10.1503/jpn.190030. [Epub ahead of print]

2.

Interrelationship Between Cognitive Control, Anxiety, and Restricted and Repetitive Behaviors in Children with 22q11.2 Deletion Syndrome.

Uljarević M, McCabe KL, Angkustsiri K, Simon TJ, Hardan AY.

Autism Res. 2019 Aug 21. doi: 10.1002/aur.2194. [Epub ahead of print]

PMID:
31433576
3.

A Pivotal Response Treatment Package for Children With Autism Spectrum Disorder: An RCT.

Gengoux GW, Abrams DA, Schuck R, Millan ME, Libove R, Ardel CM, Phillips JM, Fox M, Frazier TW, Hardan AY.

Pediatrics. 2019 Sep;144(3). pii: e20190178. doi: 10.1542/peds.2019-0178. Epub 2019 Aug 6.

PMID:
31387868
4.

Mapping the Research Domain Criteria Social Processes Constructs to the Social Responsiveness Scale.

Uljarević M, Frazier TW, Phillips JM, Jo B, Littlefield S, Hardan AY.

J Am Acad Child Adolesc Psychiatry. 2019 Jul 31. pii: S0890-8567(19)31431-5. doi: 10.1016/j.jaac.2019.07.938. [Epub ahead of print]

PMID:
31376500
5.

Blood oxytocin concentration positively predicts contagious yawning behavior in children with autism spectrum disorder.

Mariscal MG, Oztan O, Rose SM, Libove RA, Jackson LP, Sumiyoshi RD, Trujillo TH, Carson DS, Phillips JM, Garner JP, Hardan AY, Parker KJ.

Autism Res. 2019 Aug;12(8):1156-1161. doi: 10.1002/aur.2135. Epub 2019 May 27.

PMID:
31132232
6.

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism.

Parker KJ, Oztan O, Libove RA, Mohsin N, Karhson DS, Sumiyoshi RD, Summers JE, Hinman KE, Motonaga KS, Phillips JM, Carson DS, Fung LK, Garner JP, Hardan AY.

Sci Transl Med. 2019 May 8;11(491). pii: eaau7356. doi: 10.1126/scitranslmed.aau7356. Epub 2019 May 1.

PMID:
31043522
7.

Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies.

Hardan AY, Hendren RL, Aman MG, Robb A, Melmed RD, Andersen KA, Luchini R, Rahman R, Ali S, Jia XD, Mallick M, Lateiner JE, Palmer RH, Graham SM.

Autism. 2019 Nov;23(8):2096-2111. doi: 10.1177/1362361318824103. Epub 2019 Apr 26.

8.

A non randomized mentalization intervention for parents of children with autism.

Enav Y, Erhard-Weiss D, Kopelman M, Samson AC, Mehta S, Gross JJ, Hardan AY.

Autism Res. 2019 Jul;12(7):1077-1086. doi: 10.1002/aur.2108. Epub 2019 Apr 19.

PMID:
31002483
9.

A pilot investigation of neuroimaging predictors for the benefits from pivotal response treatment for children with autism.

Hegarty JP, Gengoux GW, Berquist KL, Millán ME, Tamura SM, Karve S, Rosenthal MD, Phillips JM, Hardan AY.

J Psychiatr Res. 2019 Apr;111:140-144. doi: 10.1016/j.jpsychires.2019.02.001. Epub 2019 Feb 5.

PMID:
30771619
10.

Genetic and environmental influences on structural brain measures in twins with autism spectrum disorder.

Hegarty JP 2nd, Pegoraro LFL, Lazzeroni LC, Raman MM, Hallmayer JF, Monterrey JC, Cleveland SC, Wolke ON, Phillips JM, Reiss AL, Hardan AY.

Mol Psychiatry. 2019 Jan 18. doi: 10.1038/s41380-018-0330-z. [Epub ahead of print]

11.

Development and Validation of Objective and Quantitative Eye Tracking-Based Measures of Autism Risk and Symptom Levels.

Frazier TW, Klingemier EW, Parikh S, Speer L, Strauss MS, Eng C, Hardan AY, Youngstrom EA.

J Am Acad Child Adolesc Psychiatry. 2018 Nov;57(11):858-866. doi: 10.1016/j.jaac.2018.06.023. Epub 2018 Sep 13.

12.

Cerebrospinal fluid vasopressin and symptom severity in children with autism.

Oztan O, Garner JP, Partap S, Sherr EH, Hardan AY, Farmer C, Thurm A, Swedo SE, Parker KJ.

Ann Neurol. 2018 Oct;84(4):611-615. doi: 10.1002/ana.25314. Epub 2018 Sep 26.

13.

Effects of a parent-implemented Developmental Reciprocity Treatment Program for children with autism spectrum disorder.

Gengoux GW, Schapp S, Burton S, Ardel CM, Libove RA, Baldi G, Berquist KL, Phillips JM, Hardan AY.

Autism. 2019 Apr;23(3):713-725. doi: 10.1177/1362361318775538. Epub 2018 May 18.

PMID:
29775078
14.

Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates.

Parker KJ, Garner JP, Oztan O, Tarara ER, Li J, Sclafani V, Del Rosso LA, Chun K, Berquist SW, Chez MG, Partap S, Hardan AY, Sherr EH, Capitanio JP.

Sci Transl Med. 2018 May 2;10(439). pii: eaam9100. doi: 10.1126/scitranslmed.aam9100.

15.

Plasma anandamide concentrations are lower in children with autism spectrum disorder.

Karhson DS, Krasinska KM, Dallaire JA, Libove RA, Phillips JM, Chien AS, Garner JP, Hardan AY, Parker KJ.

Mol Autism. 2018 Mar 12;9:18. doi: 10.1186/s13229-018-0203-y. eCollection 2018.

16.

Biomarker discovery for disease status and symptom severity in children with autism.

Oztan O, Jackson LP, Libove RA, Sumiyoshi RD, Phillips JM, Garner JP, Hardan AY, Parker KJ.

Psychoneuroendocrinology. 2018 Mar;89:39-45. doi: 10.1016/j.psyneuen.2017.12.022. Epub 2017 Dec 28.

17.

Video modeling for the development of personal hygiene skills in youth with autism spectrum disorder.

Piccin S, Crippa A, Nobile M, Hardan AY, Brambilla P.

Epidemiol Psychiatr Sci. 2018 Apr;27(2):127-132. doi: 10.1017/S2045796017000610. Epub 2017 Nov 10.

PMID:
29122040
18.

A proton MR spectroscopy study of the thalamus in twins with autism spectrum disorder.

Hegarty JP 2nd, Gu M, Spielman DM, Cleveland SC, Hallmayer JF, Lazzeroni LC, Raman MM, Frazier TW, Phillips JM, Reiss AL, Hardan AY.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:153-160. doi: 10.1016/j.pnpbp.2017.09.016. Epub 2017 Sep 21.

19.

Adaptive behavior in autism: Minimal clinically important differences on the Vineland-II.

Chatham CH, Taylor KI, Charman T, Liogier D'ardhuy X, Eule E, Fedele A, Hardan AY, Loth E, Murtagh L, Del Valle Rubido M, San Jose Caceres A, Sevigny J, Sikich L, Snyder L, Tillmann JE, Ventola PE, Walton-Bowen KL, Wang PP, Willgoss T, Bolognani F.

Autism Res. 2018 Feb;11(2):270-283. doi: 10.1002/aur.1874. Epub 2017 Sep 21.

20.

Intranasal oxytocin treatment for social deficits and biomarkers of response in children with autism.

Parker KJ, Oztan O, Libove RA, Sumiyoshi RD, Jackson LP, Karhson DS, Summers JE, Hinman KE, Motonaga KS, Phillips JM, Carson DS, Garner JP, Hardan AY.

Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):8119-8124. doi: 10.1073/pnas.1705521114. Epub 2017 Jul 10.

21.

A Meta-Analysis of Gaze Differences to Social and Nonsocial Information Between Individuals With and Without Autism.

Frazier TW, Strauss M, Klingemier EW, Zetzer EE, Hardan AY, Eng C, Youngstrom EA.

J Am Acad Child Adolesc Psychiatry. 2017 Jul;56(7):546-555. doi: 10.1016/j.jaac.2017.05.005. Epub 2017 May 11. Review.

22.

Incidental brain MRI findings in an autism twin study.

Monterrey JC, Philips J, Cleveland S, Tanaka S, Barnes P, Hallmayer JF, Reiss AL, Lazzeroni LC, Hardan AY.

Autism Res. 2017 Jan;10(1):113-120. doi: 10.1002/aur.1720. Epub 2016 Nov 22.

PMID:
27874265
23.

Endocannabinoid signaling in social functioning: an RDoC perspective.

Karhson DS, Hardan AY, Parker KJ.

Transl Psychiatry. 2016 Sep 27;6(9):e905. doi: 10.1038/tp.2016.169. Review.

24.

White matter structure in the uncinate fasciculus: Implications for socio-affective deficits in Autism Spectrum Disorder.

Samson AC, Dougherty RF, Lee IA, Phillips JM, Gross JJ, Hardan AY.

Psychiatry Res Neuroimaging. 2016 Sep 30;255:66-74. doi: 10.1016/j.pscychresns.2016.08.004. Epub 2016 Aug 13.

PMID:
27552717
25.

Equivalence of symptom dimensions in females and males with autism.

Frazier TW, Hardan AY.

Autism. 2017 Aug;21(6):749-759. doi: 10.1177/1362361316660066. Epub 2016 Aug 7.

PMID:
27503465
26.

The Fourth International Symposium on Genetic Disorders of the Ras/MAPK pathway.

Stevenson DA, Schill L, Schoyer L, Andresen BS, Bakker A, Bayrak-Toydemir P, Burkitt-Wright E, Chatfield K, Elefteriou F, Elgersma Y, Fisher MJ, Franz D, Gelb BD, Goriely A, Gripp KW, Hardan AY, Keppler-Noreuil KM, Kerr B, Korf B, Leoni C, McCormick F, Plotkin SR, Rauen KA, Reilly K, Roberts A, Sandler A, Siegel D, Walsh K, Widemann BC.

Am J Med Genet A. 2016 Aug;170(8):1959-66. doi: 10.1002/ajmg.a.37723. Epub 2016 May 7.

27.

Development of an Objective Autism Risk Index Using Remote Eye Tracking.

Frazier TW, Klingemier EW, Beukemann M, Speer L, Markowitz L, Parikh S, Wexberg S, Giuliano K, Schulte E, Delahunty C, Ahuja V, Eng C, Manos MJ, Hardan AY, Youngstrom EA, Strauss MS.

J Am Acad Child Adolesc Psychiatry. 2016 Apr;55(4):301-9. doi: 10.1016/j.jaac.2016.01.011. Epub 2016 Feb 4.

28.

Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension.

Aman MG, Findling RL, Hardan AY, Hendren RL, Melmed RD, Kehinde-Nelson O, Hsu HA, Trugman JM, Palmer RH, Graham SM, Gage AT, Perhach JL, Katz E.

J Child Adolesc Psychopharmacol. 2017 Jun;27(5):403-412. doi: 10.1089/cap.2015.0146. Epub 2016 Mar 15.

29.

Irritability and Problem Behavior in Autism Spectrum Disorder: A Practice Pathway for Pediatric Primary Care.

McGuire K, Fung LK, Hagopian L, Vasa RA, Mahajan R, Bernal P, Silberman AE, Wolfe A, Coury DL, Hardan AY, Veenstra-VanderWeele J, Whitaker AH.

Pediatrics. 2016 Feb;137 Suppl 2:S136-48. doi: 10.1542/peds.2015-2851L. Epub 2016 Feb 1.

30.

Pharmacologic Treatment of Severe Irritability and Problem Behaviors in Autism: A Systematic Review and Meta-analysis.

Fung LK, Mahajan R, Nozzolillo A, Bernal P, Krasner A, Jo B, Coury D, Whitaker A, Veenstra-Vanderweele J, Hardan AY.

Pediatrics. 2016 Feb;137 Suppl 2:S124-35. doi: 10.1542/peds.2015-2851K. Review.

31.

A proton spectroscopy study of white matter in children with autism.

Hardan AY, Fung LK, Frazier T, Berquist SW, Minshew NJ, Keshavan MS, Stanley JA.

Prog Neuropsychopharmacol Biol Psychiatry. 2016 Apr 3;66:48-53. doi: 10.1016/j.pnpbp.2015.11.005. Epub 2015 Nov 16.

32.

Quantitative autism symptom patterns recapitulate differential mechanisms of genetic transmission in single and multiple incidence families.

Frazier TW, Youngstrom EA, Hardan AY, Georgiades S, Constantino JN, Eng C.

Mol Autism. 2015 Oct 27;6:58. doi: 10.1186/s13229-015-0050-z. eCollection 2015.

33.

Arginine Vasopressin Is a Blood-Based Biomarker of Social Functioning in Children with Autism.

Carson DS, Garner JP, Hyde SA, Libove RA, Berquist SW, Hornbeak KB, Jackson LP, Sumiyoshi RD, Howerton CL, Hannah SL, Partap S, Phillips JM, Hardan AY, Parker KJ.

PLoS One. 2015 Jul 22;10(7):e0132224. doi: 10.1371/journal.pone.0132224. eCollection 2015.

34.

Developing Medications Targeting Glutamatergic Dysfunction in Autism: Progress to Date.

Fung LK, Hardan AY.

CNS Drugs. 2015 Jun;29(6):453-63. doi: 10.1007/s40263-015-0252-0. Review.

35.

Pivotal Response Treatment Parent Training for Autism: Findings from a 3-Month Follow-Up Evaluation.

Gengoux GW, Berquist KL, Salzman E, Schapp S, Phillips JM, Frazier TW, Minjarez MB, Hardan AY.

J Autism Dev Disord. 2015 Sep;45(9):2889-98. doi: 10.1007/s10803-015-2452-3.

PMID:
25911977
36.

Maladaptive Behavior in Autism Spectrum Disorder: The Role of Emotion Experience and Emotion Regulation.

Samson AC, Hardan AY, Lee IA, Phillips JM, Gross JJ.

J Autism Dev Disord. 2015 Nov;45(11):3424-32. doi: 10.1007/s10803-015-2388-7.

PMID:
25711546
37.

Emotion regulation in autism spectrum disorder: evidence from parent interviews and children's daily diaries.

Samson AC, Wells WM, Phillips JM, Hardan AY, Gross JJ.

J Child Psychol Psychiatry. 2015 Aug;56(8):903-13. doi: 10.1111/jcpp.12370. Epub 2014 Dec 1.

PMID:
25442191
38.

Cerebrospinal fluid and plasma oxytocin concentrations are positively correlated and negatively predict anxiety in children.

Carson DS, Berquist SW, Trujillo TH, Garner JP, Hannah SL, Hyde SA, Sumiyoshi RD, Jackson LP, Moss JK, Strehlow MC, Cheshier SH, Partap S, Hardan AY, Parker KJ.

Mol Psychiatry. 2015 Sep;20(9):1085-90. doi: 10.1038/mp.2014.132. Epub 2014 Nov 4.

PMID:
25349162
39.

A randomized controlled trial of Pivotal Response Treatment Group for parents of children with autism.

Hardan AY, Gengoux GW, Berquist KL, Libove RA, Ardel CM, Phillips J, Frazier TW, Minjarez MB.

J Child Psychol Psychiatry. 2015 Aug;56(8):884-92. doi: 10.1111/jcpp.12354. Epub 2014 Oct 27.

PMID:
25346345
40.

Autism in DSM-5 under the microscope: implications to patients, families, clinicians, and researchers.

Fung LK, Hardan AY.

Asian J Psychiatr. 2014 Oct;11:93-7. doi: 10.1016/j.ajp.2014.08.010. Epub 2014 Sep 3. Review.

PMID:
25219947
41.

Plasma vasopressin concentrations positively predict cerebrospinal fluid vasopressin concentrations in human neonates.

Carson DS, Howerton CL, Garner JP, Hyde SA, Clark CL, Hardan AY, Penn AA, Parker KJ.

Peptides. 2014 Nov;61:12-6. doi: 10.1016/j.peptides.2014.08.003. Epub 2014 Aug 19.

PMID:
25148831
42.

Plasma oxytocin concentrations and OXTR polymorphisms predict social impairments in children with and without autism spectrum disorder.

Parker KJ, Garner JP, Libove RA, Hyde SA, Hornbeak KB, Carson DS, Liao CP, Phillips JM, Hallmayer JF, Hardan AY.

Proc Natl Acad Sci U S A. 2014 Aug 19;111(33):12258-63. doi: 10.1073/pnas.1402236111. Epub 2014 Aug 4.

43.

Emotion regulation in children and adolescents with autism spectrum disorder.

Samson AC, Hardan AY, Podell RW, Phillips JM, Gross JJ.

Autism Res. 2015 Feb;8(1):9-18. doi: 10.1002/aur.1387. Epub 2014 May 23.

PMID:
24863869
44.

Brief report: an open-label study of the neurosteroid pregnenolone in adults with autism spectrum disorder.

Fung LK, Libove RA, Phillips J, Haddad F, Hardan AY.

J Autism Dev Disord. 2014 Nov;44(11):2971-7. doi: 10.1007/s10803-014-2144-4.

45.

Dr. Frazier et al. reply.

Frazier TW, Georgiades S, Bishop SL, Hardan AY.

J Am Acad Child Adolesc Psychiatry. 2014 Jun;53(6):700-1. doi: 10.1016/j.jaac.2014.04.002. No abstract available.

PMID:
24839891
46.

Basal ganglia and restricted and repetitive behaviours in Autism Spectrum Disorders: current status and future perspectives.

Calderoni S, Bellani M, Hardan AY, Muratori F, Brambilla P.

Epidemiol Psychiatr Sci. 2014 Sep;23(3):235-8. doi: 10.1017/S2045796014000171. Epub 2014 May 12.

PMID:
24816251
47.

A twin study of heritable and shared environmental contributions to autism.

Frazier TW, Thompson L, Youngstrom EA, Law P, Hardan AY, Eng C, Morris N.

J Autism Dev Disord. 2014 Aug;44(8):2013-25. doi: 10.1007/s10803-014-2081-2.

48.

A scoring strategy combining statistics and functional genomics supports a possible role for common polygenic variation in autism.

Carayol J, Schellenberg GD, Dombroski B, Amiet C, Génin B, Fontaine K, Rousseau F, Vazart C, Cohen D, Frazier TW, Hardan AY, Dawson G, Rio Frio T.

Front Genet. 2014 Feb 18;5:33. doi: 10.3389/fgene.2014.00033. eCollection 2014.

49.

Behavioral and cognitive characteristics of females and males with autism in the Simons Simplex Collection.

Frazier TW, Georgiades S, Bishop SL, Hardan AY.

J Am Acad Child Adolesc Psychiatry. 2014 Mar;53(3):329-40.e1-3. doi: 10.1016/j.jaac.2013.12.004. Epub 2013 Dec 24.

50.

Emotion dysregulation and the core features of autism spectrum disorder.

Samson AC, Phillips JM, Parker KJ, Shah S, Gross JJ, Hardan AY.

J Autism Dev Disord. 2014 Jul;44(7):1766-72. doi: 10.1007/s10803-013-2022-5.

PMID:
24362795

Supplemental Content

Loading ...
Support Center